Stefan Symeonides

12PUBLICATIONS
130CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer geneticsMolecular targetsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 01, 2026
Safety and activity of RO7300490, a bispecific CD40 agonist targeted to fibroblast activation protein, in patients with advanced solid tumors: a single-arm, multicenter, first-in-human, phase 1 trial.

|Jan 23, 2026
International Consensus-Driven Recommendations for Patient-Reported Outcome Research Objectives in Early Phase Dose-Finding Oncology Trials: OPTIMISE-ROR.

Emily Alger, Olalekan Lee Aiyegbusi, Amylou C Dueck

|Nov 08, 2025
Experimental Cancer Medicine Centre (ECMC) network proposal for a consensus gene panel for pan-cancer sequencing: a Delphi methodology.

Richard Phillips, Bristi Basu, Zohra Butt

|Jul 12, 2025
Seamless monotherapy-combination phase I dose-escalation model-based design.

Libby Daniells, Thomas Jaki, Alimu Dayimu

|Jun 27, 2025
Defactinib with avutometinib in patients with solid tumors: the phase 1 FRAME trial.

Susana Banerjee, Matthew G Krebs, Alastair Greystoke

|May 02, 2025
MANIFEST: Multiomic Platform for Cancer Immunotherapy.

Kok Haw Jonathan Lim, Zayd Tippu, Pippa G Corrie

Pageof 2

Frequent Collaborators

2 joint publications

Udai Banerji

2 joint publications

Christina Yap

2 joint publications

Victor Moreno

2 joint publications

Juanita Lopez